Potential protection from toxicity by oral iron chelators

被引：41
|
作者：
Hider, RC
机构：
[1] Department of Pharmacy, King's College London, London, SW3 6LX, Manresa Road
来源：
TOXICOLOGY LETTERS | 1995年 / 82-3卷
关键词：
iron chelators; oral activity; metalloenzymes; hydroxypyridinones; cell cycle;
D O I：
10.1016/0378-4274(95)03606-7
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
The design of clinically useful iron chelators requires attention to be paid to 3 key parameters: oral absorption, selectivity and affinity for iron(III) and toxicity. Factors which influence these 3 parameters are discussed. Hydroxypyridinones are identified as key ligands and properties leading to minimal toxicity and optimum distribution for the treatment of thalassaemia are presented. Key metalloenzymes which are inhibited by iron chelators are identified.
引用
收藏
页码：961 / 967
页数：7
相关论文
共 50 条
  • [31] Piperazine derivatives as iron chelators: a potential application in neurobiology
    Abdelsayed, S.
    Ha Duong, N. T.
    Bureau, C.
    Michel, P. P.
    Hirsch, E. C.
    Chahine, J. M. El Hage
    Serradji, N.
    BIOMETALS, 2015, 28 (06) : 1043 - 1061
  • [32] The Potential of Plant-Based Compounds As Iron Chelators
    Lane, Sarah
    Viand, Farzam
    Bolduc, Kayla
    Ehlting, Juergen
    Walter, Patrick B.
    BLOOD, 2018, 132
  • [33] The potential application of iron chelators for the treatment of neurodegenerative diseases
    Hider, Robert C.
    Roy, Sourav
    Ma, Yong Min
    Le Kong, Xiao
    Preston, Jane
    METALLOMICS, 2011, 3 (03) : 239 - 249
  • [34] Iron chelators protect from aminoglycoside-induced cochleo- and vestibulo-toxicity
    Song, BB
    Sha, SH
    Schacht, J
    FREE RADICAL BIOLOGY AND MEDICINE, 1998, 25 (02) : 189 - 195
  • [35] INVIVO TESTING OF ORAL IRON CHELATORS INTENDED FOR CLINICAL USE
    KONTOGHIORGHES, G
    BLOOD, 1991, 78 (02) : 535 - 536
  • [36] Therapeutic iron chelators and their potential side-effects
    Singh, S
    Khodr, H
    Taylor, MI
    Hider, RC
    FREE RADICALS AND OXIDATIVE STRESS: ENVIRONMENT, DRUGS AND FOOD ADDITIVES, 1995, (61): : 127 - 137
  • [37] Therapeutic potential of iron chelators on osteoporosis and their cellular mechanisms
    Zhang, Jian
    Zhao, Hai
    Yao, Gang
    Qiao, Penghai
    Li, Longfei
    Wu, Shuguang
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 137
  • [38] Piperazine derivatives as iron chelators: a potential application in neurobiology
    S. Abdelsayed
    N. T. Ha Duong
    C. Bureau
    P. P. Michel
    E. C. Hirsch
    J. M. El Hage Chahine
    N. Serradji
    BioMetals, 2015, 28 : 1043 - 1061
  • [39] Desferrithiocin analogue iron chelators: iron clearing efficiency, tissue distribution, and renal toxicity
    Bergeron, Raymond J.
    Wiegand, Jan
    Bharti, Neelam
    McManis, James S.
    Singh, Shailendra
    BIOMETALS, 2011, 24 (02) : 239 - 258
  • [40] Design and evaluation of bi-functional iron chelators for protection of dopaminergic neurons from toxicants
    Simon Gutbier
    Sotiris Kyriakou
    Stefan Schildknecht
    Anna-Katharina Ückert
    Markus Brüll
    Frank Lewis
    David Dickens
    Liam Pearson
    Joanna L. Elson
    Sylvia Michel
    Véronique Hubscher-Bruder
    Jeremy Brandel
    David Tetard
    Marcel Leist
    Ilse S. Pienaar
    Archives of Toxicology, 2020, 94 : 3105 - 3123
12345